UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

 

Filed by the Registrant þ

Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

 

  Preliminary Proxy Statement
   
  Confidential, for Use of the Commission Only (as permitted by Rule 14a- 6(e)(2) )
   
  Definitive Proxy Statement
   
þ   Definitive Additional Materials
   
  Soliciting Material Pursuant to §240.14a-12

 

CHINA PHARMA HOLDINGS, INC.

(Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

þ   No fee required.
   
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

  (1)   Title of each class of securities to which transaction applies:
   
       
   
  (2)   Aggregate number of securities to which transaction applies:
   
       
   
  (3)   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
   
       
   
  (4)   Proposed maximum aggregate value of transaction:
   
       
   
  (5)   Total fee paid:
   
       

 

  Fee paid previously with preliminary materials.
     
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

  (1)   Amount Previously Paid:
   
       
   
  (2)   Form, Schedule or Registration Statement No.:
   
       
   
  (3)   Filing Party:
   
       
   
  (4)   Date Filed:
   
       

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CHINA PHARMA HOLDINGS, INC. CONTROL ID:  
REQUEST ID:  
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
for the Annual Meeting of Stockholders
  DATE: December 5, 2018 (local time), December 4, 2018 (eastern time)
  TIME: 9:00 a.m. local time, 8:00 pm eastern time
  LOCATION: Conference Room, 2nd Floor, Jiahai Building, No. 17 Jinpan Road, Haikou, Hainan Province, China 570216
HOW TO REQUEST PAPER COPIES OF OUR MATERIALS

PHONE:

Call toll free
1-866-752-8683

FAX:

Send this card to
202-521-3464

INTERNET:
https://www.iproxydirect.com/CPHI
and follow the on-screen instructions.

EMAIL:

proxy@iproxydirect.com
Include your Control ID in your email.

 
This communication represents a notice to access a more complete set of proxy materials available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The proxy statement is available at: https://www.iproxydirect.com/CPHI
 
If you want to receive a paper copy of the proxy materials you must request one. There is no charge to you for requesting a copy.  To facilitate timely delivery please make the request, as instructed above, before November 23, 2018.
 
you may enter your voting instructions at https://www.iproxydirect.com/CPHI
until 11:59 pm eastern time December 3, 2018
  The purposes of this meeting are as follows:   
 

1.     To elect five director nominees to our Board of Directors to serve until the next annual meeting (for non-executive directors) or until the annual meeting in three years (for executive directors) and until their successors are elected and qualified; and

 

2.     To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.

 

Pursuant to Securities and Exchange Commission rules, you are receiving this Notice that the proxy materials for the Annual meeting are available on the Internet. Follow the instructions above to view the materials and vote or request printed copies.

 

The board of directors has fixed the close of business on October 15, 2018 as the record date for the determination of stockholders entitled to receive notice of the Annual Meeting and to vote the shares of our common stock and Series A Convertible Preferred Stock.

 

THE BOARD, INCLUDING THE INDEPENDENT DIRECTORS, UNANIMOUSLY RECOMMENDS THAT YOU VOTE

FOR ALLEACH OF THE NOMINEES IN PROPOSAL ONE.

 
Please note - This is not a Proxy Card - you cannot vote by returning this card

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CHINA PHARMA HOLDINGS, INC.

SHAREHOLDER SERVICES

500 Perimeter Park Drive Suite D

Morrisville NC 27560

FIRST-CLASS MAIL

US POSTAGE

PAID

RALEIGH NC

PERMIT # 870

 

 

 

 

 

Time Sensitive shareholder information enclosed

 

 

 

 

 

 

 

 

 

IMPORTANT SHAREHOLDER INFORMATION

 

your vote is important

 

 

 

 

 

 

 

 

 

 

 

 

 

CHINA PHARMA HOLDINGS, INC.

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

annual meeting OF STOCKHOLDERS – december 4, 2018 at 8:00 p.m. Eastern Time (December 5, 2018 at 9:00 a.m. local time)

 

       
CONTROL ID:              
REQUEST ID:              
               
             
This Proxy is Solicited on Behalf of the Board of Directors of China Pharma Holdings, Inc. The undersigned hereby appoints Zhilin Li as proxy, with full power of substitution, to vote as designated below all of the shares the undersigned is entitled to vote at the Annual Meeting of Stockholders to be held at the Conference Room, 2nd Floor, Jiahai Building, No. 17 Jinpan Road, Haikou, Hainan Province, China 570216 on Wednesday, December 5, 2018, at 9:00 a.m. local time (Tuesday, December 4, 2018 at 8:00 p.m., Eastern Time), and any adjournments or postponements thereof, and otherwise to represent the undersigned at the meeting, with all powers possessed by the undersigned if personally present at the meeting.
   
(CONTINUED AND TO BE SIGNED ON REVERSE SIDE.)
             
             
VOTING INSTRUCTIONS            
If you vote by phone, fax or internet, please DO NOT mail your proxy card.            
             
           

 

 

 

 

 

 

MAIL: Please mark, sign, date, and return this Proxy Card promptly using the enclosed envelope.          
FAX: Complete the reverse portion of this Proxy Card and Fax to 202-521-3464.          
INTERNET: https://www.iproxydirect.com/CPHI          
PHONE: 1-866-752-VOTE(8683)          
               
       
         
         
         
         
                         

 

 

 

ANNUAL MEETING OF THE STOCKHOLDERS OF
CHINA PHARMA HOLDINGS, INC.

PLEASE COMPLETE, DATE, SIGN AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE.
PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE: ☒
   
PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS  
       
Proposal 1   à FOR
ALL
 

AGAINST

ALL

 

FOR ALL

EXCEPT

     
  To elect five director nominees to our Board of Directors to serve until the next annual meeting (for non-executive directors) or until the annual meeting in three years (for executive directors) and until their successors are elected and qualified:              
  Zhilin Li                
  Heung Mei Tsui             Control ID:  
  Gene Michael Bennett             REQUEST ID:  
  Yingwen Zhang                
  Baowen Dong                
Proposal 2                    
  To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.                  
          MARK “X” HERE IF YOU PLAN TO ATTEND THE MEETING: ☐
Our Board of Directors recommends a vote “FOR ALL” election of each of the nominees listed in Proposal 1.

 

 

   

MARK HERE FOR ADDRESS CHANGE ☐ New Address (if applicable):

____________________________
____________________________
____________________________

 

IMPORTANT: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.

 

Dated: ________________________, 2018

 
 

(Print Name of Stockholder and/or Joint Tenant)

 

 

(Signature of Stockholder)

 

 
(Second Signature if held jointly)